McClellan on Follow-on Biologics: It's the Science
Mark McClellan's spoke to the generic trade group about follow on biologics. In a word, focus on working with the FDA to develop the science for FOBs instead of just ramming through the current legislation which could, because it is devoid of science, could set FOBs back a decade. In this regard, Hillary Clinton appears to have moved into the science-based camp and has called for more clinical testing and post marketing monitoring of FOBs. Good for her. It shows she is serious about the subject.